Private Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Buy |
197,086
+862
| +0.4% | +$69K | 0.95% | 26 |
|
|
2025
Q4 | $18.7M | Sell |
196,224
-8,945
| -4% | -$877K | 1.33% | 22 |
|
|
2025
Q3 | $20M | Sell |
205,169
-267
| -0.1% | -$27.7K | 1.43% | 20 |
|
|
2025
Q2 | $22.1M | Sell |
205,436
-18,631
| -8% | -$1.89M | 1.72% | 19 |
|
|
2025
Q1 | $22.6M | Sell |
224,067
-4,249
| -2% | -$428K | 1.87% | 17 |
|
|
2024
Q4 | $20.4M | Sell |
228,316
-3,895
| -2% | -$343K | 1.56% | 20 |
|
|
2024
Q3 | $19.5M | Sell |
232,211
-720
| -0.3% | -$56.8K | 1.55% | 19 |
|
|
2024
Q2 | $17.9M | Buy |
232,931
+577
| +0.2% | +$42.2K | 1.33% | 21 |
|
|
2024
Q1 | $15.9M | Sell |
232,354
-1,010
| -0.4% | -$64.9K | 1.27% | 23 |
|
|
2023
Q4 | $13.5M | Sell |
233,364
-415
| -0.2% | -$22.2K | 1.14% | 25 |
|
|
2023
Q3 | $12.3M | Sell |
233,779
-2,715
| -1% | -$142K | 1.18% | 25 |
|
|
2023
Q2 | $12.8M | Hold |
236,494
| – | – | 1.18% | 24 |
|
|
2023
Q1 | $11.8M | Buy |
236,494
+650
| +0.3% | +$30.6K | 1.18% | 23 |
|
|
2022
Q4 | $10.9M | Buy |
235,844
+1,202
| +0.5% | +$52K | 1.25% | 24 |
|
|
2022
Q3 | $9.09M | Sell |
234,642
-11,800
| -5% | -$473K | 1.16% | 25 |
|
|
2022
Q2 | $9.19M | Sell |
246,442
-66,521
| -21% | -$2.71M | 1.07% | 30 |
|
|
2022
Q1 | $13.9M | Sell |
312,963
-47,985
| -13% | -$2.08M | 1.24% | 27 |
|
|
2021
Q4 | $15.3M | Sell |
360,948
-714
| -0.2% | -$30K | 1.3% | 26 |
|
|
2021
Q3 | $15.7M | Buy |
361,662
+2,675
| +0.7% | +$118K | 1.46% | 23 |
|
|
2021
Q2 | $15.3M | Buy |
358,987
+798
| +0.2% | +$33.6K | 1.42% | 23 |
|
|
2021
Q1 | $13.8M | Buy |
358,189
+1,802
| +0.5% | +$68.2K | 1.47% | 24 |
|
|
2020
Q4 | $12.8M | Buy |
356,387
+4,475
| +1% | +$161K | 1.39% | 23 |
|
|
2020
Q3 | $13.4M | Buy |
351,912
+2,163
| +0.6% | +$83.3K | 1.57% | 17 |
|
|
2020
Q2 | $12.3M | Sell |
349,749
-18,016
| -5% | -$649K | 1.68% | 17 |
|
|
2020
Q1 | $12M | Sell |
367,765
-48,662
| -12% | -$1.9M | 2.02% | 15 |
|
|
2019
Q4 | $18.8M | Buy |
416,427
+4,736
| +1% | +$198K | 2.57% | 10 |
|
|
2019
Q3 | $16.8M | Sell |
411,691
-6,143
| -1% | -$260K | 2.61% | 12 |
|
|
2019
Q2 | $18M | Buy |
417,834
+16,234
| +4% | +$624K | 2.76% | 11 |
|
|
2019
Q1 | $15.4M | Buy |
401,600
+994
| +0.2% | +$38K | 2.53% | 12 |
|
|
2018
Q4 | $14.2M | Buy |
400,606
+2,428
| +0.6% | +$88.1K | 2.74% | 12 |
|
|
2018
Q3 | $15.3M | Sell |
398,178
-1,747
| -0.4% | -$61K | 2.34% | 13 |
|
|
2018
Q2 | $13.1M | Sell |
399,925
-2,733
| -0.7% | -$82.4K | 2.2% | 14 |
|
|
2018
Q1 | $11M | Buy |
402,658
+116,263
| +41% | +$3.16M | 1.92% | 17 |
|
|
2017
Q4 | $7.1M | Buy |
286,395
+76,525
| +36% | +$2.11M | 1.31% | 27 |
|
|
2017
Q3 | $6.12M | Buy |
209,870
+1,819
| +0.9% | +$50.2K | 1.23% | 27 |
|
|
2017
Q2 | $5.77M | Buy |
208,051
+785
| +0.4% | +$20.8K | 1.25% | 24 |
|
|
2017
Q1 | $5.16M | Buy |
207,266
+6,796
| +3% | +$165K | 1.14% | 27 |
|
|
2016
Q4 | $4.34M | Buy |
+200,470
| New | +$4.37M | 1.03% | 29 |
|
|
2016
Q3 | – | Sell |
-13,000
| Closed | -$304K | – | 122 |
|
|
2016
Q2 | $304K | Buy |
+13,000
| New | +$281K | 0.07% | 103 |
|
Other funds holding BSX
VCM
VPM
Private Wealth Partners's BSX Position: Q1 2026 in Review
Private Wealth Partners increased its Boston Scientific (BSX) stake by 0.44% in Q1 2026, buying an estimated $69K and bringing the position to 197,086 shares worth $12.4M. The position accounts for 0.95% of the portfolio, ranked #26.
Private Wealth Partners first reported a position in BSX in Q2 2016 and has held it in 39 quarters since. The position peaked at $22.6M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Private Wealth Partners held 197,086 shares of Boston Scientific worth $12.4M as of Q1 2026.
- Private Wealth Partners bought 862 Boston Scientific shares in Q1 2026, an estimated $69K.
- Boston Scientific made up 0.95% of Private Wealth Partners's portfolio in Q1 2026, its #26 holding.
- Private Wealth Partners first reported a position in Boston Scientific in Q2 2016 and has held it in 39 quarters since.
- Private Wealth Partners's Boston Scientific position peaked at $22.6M in Q1 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.